FRESENIUS MEDICAL CARE-ADR (FMS) Fundamental Analysis & Valuation

NYSE:FMS • US3580291066

Current stock price

22.79 USD
+0.04 (+0.18%)
At close:
22.79 USD
0 (0%)
After Hours:

This FMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. FMS Profitability Analysis

1.1 Basic Checks

  • In the past year FMS was profitable.
  • In the past year FMS had a positive cash flow from operations.
  • In the past 5 years FMS has always been profitable.
  • In the past 5 years FMS always reported a positive cash flow from operatings.
FMS Yearly Net Income VS EBIT VS OCF VS FCFFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • FMS has a Return On Assets of 3.16%. This is in the better half of the industry: FMS outperforms 66.34% of its industry peers.
  • FMS has a better Return On Equity (7.35%) than 64.36% of its industry peers.
  • FMS has a Return On Invested Capital (5.30%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for FMS is below the industry average of 8.98%.
  • The last Return On Invested Capital (5.30%) for FMS is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FMS Yearly ROA, ROE, ROICFMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of FMS (4.98%) is better than 79.21% of its industry peers.
  • In the last couple of years the Profit Margin of FMS has declined.
  • FMS has a better Operating Margin (9.00%) than 77.23% of its industry peers.
  • FMS's Operating Margin has declined in the last couple of years.
  • FMS has a Gross Margin (25.62%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of FMS has declined.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FMS Yearly Profit, Operating, Gross MarginsFMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. FMS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FMS is creating some value.
  • The number of shares outstanding for FMS has been reduced compared to 1 year ago.
  • FMS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for FMS is higher compared to a year ago.
FMS Yearly Shares OutstandingFMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
FMS Yearly Total Debt VS Total AssetsFMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 1.83 indicates that FMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • FMS has a Altman-Z score (1.83) which is comparable to the rest of the industry.
  • FMS has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FMS would need 6.19 years to pay back of all of its debts.
  • FMS has a Debt to FCF ratio of 6.19. This is comparable to the rest of the industry: FMS outperforms 55.45% of its industry peers.
  • A Debt/Equity ratio of 0.65 indicates that FMS is somewhat dependend on debt financing.
  • FMS has a Debt to Equity ratio of 0.65. This is comparable to the rest of the industry: FMS outperforms 56.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.83
ROIC/WACC1.02
WACC5.21%
FMS Yearly LT Debt VS Equity VS FCFFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • FMS has a Current Ratio of 1.26. This is a normal value and indicates that FMS is financially healthy and should not expect problems in meeting its short term obligations.
  • FMS has a Current ratio (1.26) which is in line with its industry peers.
  • FMS has a Quick Ratio of 1.26. This is a bad value and indicates that FMS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FMS has a Quick ratio of 0.92. This is in the lower half of the industry: FMS underperforms 70.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FMS Yearly Current Assets VS Current LiabilitesFMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. FMS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.00% over the past year.
  • FMS shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.51% yearly.
  • Looking at the last year, FMS shows a small growth in Revenue. The Revenue has grown by 1.51% in the last year.
  • Measured over the past years, FMS shows a small growth in Revenue. The Revenue has been growing by 1.91% on average per year.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • FMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.03% yearly.
  • The Revenue is expected to grow by 3.69% on average over the next years.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FMS Yearly Revenue VS EstimatesFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FMS Yearly EPS VS EstimatesFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. FMS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.46, the valuation of FMS can be described as reasonable.
  • Based on the Price/Earnings ratio, FMS is valued cheaper than 94.06% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, FMS is valued rather cheaply.
  • FMS is valuated reasonably with a Price/Forward Earnings ratio of 10.10.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 90.10% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. FMS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.46
Fwd PE 10.1
FMS Price Earnings VS Forward Price EarningsFMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 91.09% of the companies in the same industry are more expensive than FMS, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, FMS is valued cheaply inside the industry as 90.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.64
EV/EBITDA 6.08
FMS Per share dataFMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. FMS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.63%, FMS has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.49, FMS pays a better dividend. On top of this FMS pays more dividend than 98.02% of the companies listed in the same industry.
  • FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

  • The dividend of FMS has a limited annual growth rate of 4.43%.
  • FMS has paid a dividend for at least 10 years, which is a reliable track record.
  • FMS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years2
FMS Yearly Dividends per shareFMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • FMS pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FMS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FMS Yearly Income VS Free CF VS DividendFMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FMS Dividend Payout.FMS Dividend Payout, showing the Payout Ratio.FMS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

FMS Fundamentals: All Metrics, Ratios and Statistics

FRESENIUS MEDICAL CARE-ADR

NYSE:FMS (3/13/2026, 8:27:41 PM)

After market: 22.79 0 (0%)

22.79

+0.04 (+0.18%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners44.27%
Inst Owner Change6.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.37B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target27.2 (19.35%)
Short Float %0.45%
Short Ratio3.12
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend0.83
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)0.14%
PT rev (3m)-2.47%
EPS NQ rev (1m)9.36%
EPS NQ rev (3m)64.04%
EPS NY rev (1m)-5.37%
EPS NY rev (3m)-5.24%
Revenue NQ rev (1m)-4.78%
Revenue NQ rev (3m)-4.07%
Revenue NY rev (1m)-2.09%
Revenue NY rev (3m)-2.06%
Valuation
Industry RankSector Rank
PE 9.46
Fwd PE 10.1
P/S 0.59
P/FCF 6.64
P/OCF 4.32
P/B 0.87
P/tB N/A
EV/EBITDA 6.08
EPS(TTM)2.41
EY10.57%
EPS(NY)2.26
Fwd EY9.9%
FCF(TTM)3.43
FCFY15.05%
OCF(TTM)5.28
OCFY23.15%
SpS38.62
BVpS26.19
TBVpS-2.98
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.68
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.83
F-Score8
WACC5.21%
ROIC/WACC1.02
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year72.47%
EBIT Next 3Y24.27%
EBIT Next 5Y15.34%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE-ADR / FMS Fundamental Analysis FAQ

What is the fundamental rating for FMS stock?

ChartMill assigns a fundamental rating of 5 / 10 to FMS.


Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?

ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.


What is the profitability of FMS stock?

FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?

The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to decline by -6.53% in the next year.


Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?

The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 43.19%.